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Expression in the Developing Heart and Gut,” by Colin MacNeill, Randall French,
Todd Evans, Andy Wessels and John B. E. Burch, pages 62–76 (doi:10.1006/
dbio.1999.9539): The authors previously reported that the cGATA-5/lacZ-F construct
was not expressed in transient transgenic mouse embryos at E9.5 (e.g., see Fig. 1 and
Table 1). However, in light of more recent findings, they infer that this negative result
was erroneous. In particular, their analysis of a new set of cGATA-5/lacZ-F transient
transgenic mouse embryos at E9.5 clearly revealed robust expression in the septum
transversum, epicardial organ, epicardium, epicardial derived cells, compact myocar-
dium, and foregut/midgut junction in 6 (of 6) transgenic embryos (data not shown).
Based on this unambiguous positive result, the authors conclude that the cGATA-5
proximal enhancer maps to an 868-bp (SacI to NcoI) fragment 24.5 to 23.6 kb upstream
of the gene instead of the previously reported 554 bp (EcoRI to SacI) fragment 25.0 to
24.5 kb upstream of the gene (see Fig. 9). The authors confirmed and extended this
conclusion by determining that this 868-bp fragment was able to direct a similar
expression pattern in E9.5 transgenic mouse embryos when assayed in conjunction
with a heterologous promoter (data not shown). The sequence of this bona fide 868-bp
cGATA-5 proximal enhancer fragment is shown below.
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